100 N. Tucker Blvd.
St. Louis, MO 63101
United States
Saint Louis University - School of Law
SSRN RANKINGS
in Total Papers Downloads
in Total Papers Citations
COVID-19, coronavirus, vaccine, intellectual property, patent, nationalism, misinformation, disinformation, public-private partnership, World Health Organization, CEPI, Gavi, Covax, procurement, equitable vaccine distribution, Moderna, mRNA vaccine
vaccine, nationalism, COVID-19, coronavirus, pandemic, H1N1, swine flu, pre-production contracts, compulsory licensing, TRIPS Agreement, equitable access, vulnerable populations, United States, Germany
COVID-19, vaccine, waiver, manufacturing, contracts, patent, intellectual property, technology transfer, trade secrets, know-how, compulsory licensing
misinformation, coronavirus, pandemic, COVID-19, social media, Facebook, Pinterest, Youtube, Tik Tok, conspiracy theories, vaccines, patents, Bill Gates
Intellectual Property, Health, Vaccines, Preparedness, Outbreak, Pandemic, Zika, Ebola, Patent, Vaccine Development, Disease, Licensing, Dormant License, Inefficiency, Incentives, Transactional IP, Funding, R&D
vaccines, patents, health, intellectual property, outbreaks, infectious diseases, pandemics, public-private partnerships, Coalition for Epidemic Preparedness Innovations
vaccine, health, pathogen, outbreak, Salk, polio, patent, intellectual property, licensing, liability, property, Calabresi, Melamed, Reichman
Priority review voucher, Food and Drug Administration (FDA), 21st Century Cures Act, neglected diseases, Ebola, Zika, incentives
Vaccine, Zika, Army, outbreak, infectious disease, exclusivity, Patent Act, patent, technology transfer, public funding, public interest
COVID, coronavirus, intellectual property, patents, vaccines, ventilators, 3D printing, World Health Organization, nationalism, COVAX, procurement, patent pools, pledge, COVID Open Pledge
Coronavirus, COVID-19, vaccine, patent, intellectual property
Blockchain, Health, Data, Healthcare, Insurance Companies, Sweden, Estonia, Infrastructure
vaccines, intellectual property, property, Ebola, Zika, COVID-19, licensing, Oil States, liability
misinformation, disinformation, vaccine, social media, regulation, Facebook, Instagram, Twitter, YouTube, COVID-19, pandemic, measles, algorithm, bots, influencer, European Union, Russia, soft law, anti-vaccine
TC Heartland v Kraft, Venue, Patent Venue, Patent Exceptionalism, Personal Jurisdiction, Eastern District of Texas, Supreme Court, Federal Circuit
intellectual property, patent, determinants of health, socio-economic determinants of health, health, HIV, AIDS, Truvada, vaccines, medicines, remdesivir, epidemics, pandemics, Ebola, Zika, COVID-19, agtech, genetically modified food, Golden Rice, public-private partnerships, COVAX, DNDi, CEPI, Gavi
vaccine, COVID-19, nationalism, international law, contracts, sovereignty, viral sovereignty, H1N1, influenza, Ebola, pandemic, Pandemic Influenza Preparedness Framework, World Health Organization, COVAX, United States, China, India, Russia
vaccine, clinical trial, data, COVID-19, polio, H1N1, minority representation, FDA, European Medicines Agency, trade secrets, intellectual property
Intellectual property, TRIPs, BRICs, Roadmap, Brazil, India, compulsory licensing
gig economy, gig workers, essential workers, employment, labor, benefits, COVID-19, pandemic
coronavirus, COVID-19, China, World Health Organization, misinformation, disinformation, health law, health policy, Missouri, New York, Foreign Sovereignty Immunities Act
vaccine, technology, innovation, pharmaceuticals, markets, intellectual property, contracts, patent, COVID-19, pandemic, epidemic, 3D printing, artificial intelligence, nationalism
COVID-19, coronavirus, SARS-CoV-2, pandemic, pharmaceuticals, vaccines, healthcare markets, incentives, for-profit, public health, innovation, remdesivir, Food and Drug Administration, FDA, Gilead, Ebola, SARS, MERS, preparedness, private public partnerships, PPPs, emergency response
patent, pharmaceutical industry, biologics, drugs, antitrust, competition, Food and Drug Administration, intellectual property, patent term, Humira, license, revocation
COVID-19, coronavirus, necessity, lesser-evil, lesser harm, defense, privilege, intellectual property, IP, Lake Erie, Vincent v. Lake Erie, respirators, 3d printing, pharmaceuticals, public health, public necessity, private necessity, imminent harm, torts, common law, emergency
copyright, music, licensing, territoriality, collective rights management, European Commission, European law
Alzheimer's, Food and Drug Administration, FDA, pharmaceuticals, drugs, regulation, administrative law, health, Chevron
COVID-19, vaccine, payment, incentive, misinformation, disinformation, racial minorities
face shields, masks, COVID-19, coronavirus, disability, racial discrimination
Facebook, vaccine, misinformation, disinformation, social media, Instagram, Pinterest, YouTube, COVID-19, flu, speech, regulation
COVID-19, coronavirus, Portugal, state of emergency, state of calamity, constitutional law, immigration, migrants, religious holidays
COVID-19, Coronavirus, Vaccine, Tax, Health, Innovation, Patent, Intellectual Property, Pharmaceuticals, Orphan Drugs, Pandemic, Preparedness, Law, Policy
COVID-19, vaccines, social determinants of health, racial discrimination, vaccine distribution, FDA, Food and Drug Administration, CDC, Centers for Disease Control and Prevention, emergency use authorization, pandemic, epidemic, equitable allocation, distributive justice
Coronavirus, COVID-19, vaccines, intellectual property, preparedness, patents, public-private partnerships, CEPI, patent pledge
courts, judicialization, health, right to health, judicial review, Brazil, Colombia, Michigan, constitutional law
patents, intellectual property, Venice, Italy, glass, glass industry, tailored regimes, Patent and Trademark Office, TRIPS Agreement
vaccine, hesitancy, anti-vaccine, vaccination, anti-vaccination, public health, misinformation, disinformation, polio, COVID-19, social media, nudge, prize, lottery, Jacobson v. Massachusetts, Davis v. Wyeth, Reyes v. Wyeth, Occupational Safety and Health Act
Vaccines, COVID-19, Food and Drug Administration, FDA, Public Health, Vaccine Hesitancy, Emergency Use Authorization, EUA, chloroquine, hydroxychloroquine, convalescent plasma, coronavirus, pandemic, Office of Technology Assessment, OTA
vaccine, vaccination, hesitancy, staggering, vaccination schedules, alternative vaccination schedules, vaccine refusal, vaccine hesitancy, Centers for Disease Control and Prevention
health, vaccine, mandate, test, public health, Supreme Court, Occupational Safety and Health Administration, COVID-19, H1N1, swine flu
FDA, Food and Drug Administration, COVID-19, hydroxychloroquine, convalescent COVID-19 plasma, vaccines, reactivity, administrative law
Bayh-Dole, Patents, Regulations, March-In, Pricing
pandemic, epidemic, COVID-19, intellectual property, IP, know-how, access to medicine